Skip to content

Home
About Us
Main Business Clinical
- Main Business Clinical
- Clinical process
Information
- Newsletter
- Clinical Trial Information
Korea Clinical Trial Status
- Pharmaceutical Approval Status in Korea
- Medical Device Approval Status in Korea
English
- English
- 한국어

Quotation Request

Connecting people, advancing clinical value

Home
About Us
Main Business
- Main Business
- Clinical Trial Process
Information
Korea Clinical Trial Status
- Pharmaceutical Approval Status in Korea
- Medical Device Approval Status in Korea
English
- English
- 한국어

Quotation Request

Connecting people, advancing clinical value

인투인월드
2024/03/22
Newsletter_EN

[Newsletter] Vol 49. Mar 2024

HomeNewsletter_EN[Newsletter] Vol 49. Mar 2024

Newsletter Vol 49. This is the March 2024 newsletter.

[인투인월드]Newsletter Vol.49_202403 Download

Related Posts

Intoinworld Newsletter Vol.72 1

[Newsletter] Vol 72. February 2026

2026/02/26

Intoinworld Newsletter Vol.71 1

[Newsletter] Vol 71. January 2026

2026/01/23

인투인월드Newsletter Vol.70 EN

[Newsletter] Vol 70. December 2025

2025/12/19

인투인월드Newsletter Vol.69 EN 1

[Newsletter] Vol 69. November 2025

2025/11/19

Business registration number

425-87-00267

Tel

+82-2-2038-8082

E-mail

intoin@intoinworld.com

CEO

John Choi

Address

10F, 21, Gukhoe-daero 62-gil, Yeongdeungpo-gu, Seoul, 07236, Korea

Privacy Policy
Terms of Service
Email Collection Prohibited

COPYRIGHT © INTOINWORLD, ALL RIGHT RESERVED

When selecting a CRO partner, which factor matters most to you?Referral / a CRO I already knowProven experience in our therapeutic areaBudget transparencySpeed and operational responsiveness (fast start-up, quick issue resolution)Other (please specify)